RADHAKISHAN PHARMACEUTICALS
CRESP DARBEPOETIN ALFA  INJECTION

CRESP DARBEPOETIN ALFA INJECTION

CRESP DARBEPOETIN ALFA INJECTION Specification

  • Indication
  • Treatment of anemia in chronic kidney disease and chemotherapy induced anemia
  • Dosage Form
  • Injection
  • Salt Composition
  • Darbepoetin Alfa
  • Origin
  • Biotechnology/Genetically Engineered
  • Ingredients
  • Darbepoetin Alfa, excipients
  • Application
  • Increases red blood cell production
  • Ph Level
  • Approximately neutral (6.07.0)
  • Physical Color/Texture
  • Clear, colorless and aqueous solution
  • Fermentation Smell
  • Odorless
  • Storage Instructions
  • Store at 2C to 8C, do not freeze, protect from light
  • Shelf Life
  • 24 months from the date of manufacture
 

CRESP DARBEPOETIN ALFA INJECTION Trade Information

  • Packaging Details
  • PACK OF 1 VIAL
  • Main Domestic Market
  • All India
 

About CRESP DARBEPOETIN ALFA INJECTION

Cresp is manufactured By Dr. Reddys. Cresp contains Darbepoetin alfa injection.


Cresp is the world first generic version of darbepoetin alpha in the world and the only darbepoetin alfa in India. Darbepoetin alfa is a modified version of epoetin alfa, which is engineered to have a longer half life, increasing (up to 3 times) the time it remains in the blood. This results in a reduced frequency of doses, providing a simpler and more convenient treatment option for patients and physicians as compared to treatment of anaemia with epoetin which is the current standard of care in India...........

Other Information

  • Minimum Order Quantity: 1
  • Port of Dispatch: New Delhi, India

Specification

  • Drug:CRESP 100MG
  • Usage:Hospital
  • Brand:DR. REDDYS
  • Form:INJECTION
  • Packaging Type:INJECTION
  • Dose/Strength:25



How CRESP Darbepoetin Alfa Injection Works

Cresp contains genetically engineered Darbepoetin Alfa, designed to stimulate your bodys bone marrow to produce more red blood cells. This action helps alleviate anemia caused by chronic kidney disease or chemotherapy treatments, ultimately improving oxygen circulation and reducing fatigue in affected individuals.


Proper Administration of CRESP Injection

The injection can be administered subcutaneously or intravenously, depending on your doctors recommendation. It is crucial that only trained healthcare professionals carry out the process. CRESP should never be combined with other drugs in the same syringe to maintain compatibility and prevent adverse reactions.


Safety Measures and Storage Guidelines

Store CRESP Darbepoetin Alfa Injection between 2C and 8C, and ensure the solution is protected from light and not frozen. Patients with uncontrolled hypertension or known allergies should use this medicine with caution and under close medical supervision to avoid complications.

FAQs of CRESP DARBEPOETIN ALFA INJECTION:


Q: How should CRESP Darbepoetin Alfa Injection be administered?

A: CRESP Darbepoetin Alfa Injection is administered either subcutaneously (under the skin) or intravenously (into a vein), as prescribed by your healthcare provider. Only trained professionals should handle its administration to ensure correct dosage and technique.

Q: What is the primary benefit of using CRESP Darbepoetin Alfa Injection?

A: The main benefit is the treatment of anemia due to chronic kidney disease or chemotherapy. It increases the production of red blood cells, helping to raise hemoglobin levels and reduce symptoms such as fatigue and weakness.

Q: When should CRESP Darbepoetin Alfa Injection be used with caution?

A: You should use CRESP with caution if you have uncontrolled hypertension or a known hypersensitivity to its ingredients. Your doctor will carefully assess your eligibility before prescribing this medication.

Q: Where should CRESP Darbepoetin Alfa Injection be stored, and what precautions should be taken?

A: CRESP should be stored at a temperature between 2C and 8C, protected from light, and must not be frozen. Follow all storage instructions to maintain the medications effectiveness and safety.

Q: What should be avoided when preparing CRESP Darbepoetin Alfa Injection?

A: Do not mix CRESP with any other drugs in the same syringe, as it is not compatible and may result in harmful reactions. Always use a dedicated syringe as directed by your healthcare provider.

Q: Who should prescribe and administer CRESP Darbepoetin Alfa Injection?

A: Only licensed medical professionals should prescribe and administer CRESP Darbepoetin Alfa Injection, given its specific indications, prescription status, and the need for proper handling.

Tell us about your requirement
product

Price:

Quantity
Select Unit

  • 50
  • 100
  • 200
  • 250
  • 500
  • 1000+
Additional detail
Mobile number

Email

More Products in Anticancer Medicines Category

BORTENAT-BORTEZOMIB INJECTION

BORTENAT-BORTEZOMIB INJECTION

Shelf Life : 24 Months

Storage Instructions : Store below 25C, protect from light

Feature : Other, Sterile, Preservative Free

Ingredients : Other , Bortezomib

Salt Composition : Bortezomib (as Bortezomib for Injection) 2 mg/vial

Dosage Form : Injection

VEENAT 100 MG  IMATINIB CAPSULES

VEENAT 100 MG IMATINIB CAPSULES

Shelf Life : 24 Months

Storage Instructions : Store below 25C, protect from light and moisture

Feature : Other, Oral, targeted therapy, prescription only

Ingredients : Other , Imatinib Mesylate, Excipients Q.S.

Salt Composition : Imatinib Mesylate 100 mg

Dosage Form : Capsules

VEENAT IMATINIB 100MG CAPSULES

VEENAT IMATINIB 100MG CAPSULES

Shelf Life : 24 months from the date of manufacture

Storage Instructions : Store below 30C, protect from moisture and light, keep out of reach of children

Feature : Other, Targeted therapy for certain cancers, trusted brand, convenient oral dosage

Ingredients : Other , Imatinib Mesylate and excipients

Salt Composition : Imatinib Mesylate 100mg

Dosage Form : Capsules

VORIZOL VORICONAZOLE INJECTION

VORIZOL VORICONAZOLE INJECTION

Shelf Life : 24 months

Storage Instructions : Store below 25C. Protect from light and moisture.

Feature : Other, Broadspectrum antifungal, lyophilized for intravenous use

Ingredients : Other , Voriconazole, excipients (including solubilizing agents and stabilizers)

Salt Composition : Voriconazole 200 mg/vial

Dosage Form : Injection



Back to top